Download Files:
Sintilimab
Price range: 261 CAD through 2,368 CAD
Products Details
Product Description
– Sintilimab (IBI308) is a humanized IgG4 monoclonal antibody with significant anti-tumor activity that restores endogenous anti-tumor T-cell responses by binding to PD-1 and thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2).Sintilimab is used in combination with other compounds for the treatment of classical Hodgkin’s lymphoma, non-cellular lung cancer and esophageal cancer. Sintilimab is used in combination with other compounds to treat classical Hodgkin’s lymphoma, non-small cell lung cancer and esophageal cancer.
Web ID
– T35394
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Sheridan M Hoy. Sintilimab: First Global Approval Drugs. 2019 Feb;79(3):341-346.
CAS Number
– 2072873-06-2
Molecular Weight
Compound Purity
– > 95%
Target
– Others
Pathway
– Apoptosis|||Immunology/Inflammation|||Cell Cycle/Checkpoint
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
